The working questions of medical publication, put to practitioners.
In Plain Cite, from ISMPP, takes the working problems of medical publication to practitioners and asks how they handle them. Host Rob Mathias covers steering committee disputes, whether patient authors should be paid, getting publications onto social media, and how to prompt generative AI.
PRESS PLAY
In Plain Cite is ISMPP's podcast about medical publication and communication, hosted by Rob Mathias, the organization's President and CEO. It is a working professional's show, built around what happens as trial data becomes abstracts, manuscripts and congress presentations. Episodes lay out a question first and then hand it to guests who deal with it in their jobs. The steering committee conversation shows how practical it gets. Asked whether these committees always run smoothly, guests name authorship order and which data to present first as the usual points of disagreement. Their remedy is plain and specific: go back to the charter, decide beforehand whether the group works by consensus or by vote, and settle authorship against GPP and ICMJE criteria. 'Should Patient Authors Be Paid? Navigating Ethics, Equity, and Recognition' tests one of the field's firmest rules. The host states it plainly: not paying authors has been a core tenet of good publication practice for more than twenty years, so what changes when the author is a patient? One guest describes a working arrangement in which patients are paid for their part in the research under a contract that ends when the publication phase begins. The host's follow-ups push for the operational version of an answer. He does the same in the social media conversation, asking Amanda Solis and Leslie Rotz what a team with no social presence should do on its first day back in the office. Rotz recommends a stepwise approach that starts with audience insights rather than copying benchmark examples on LinkedIn and X. The panel also notes that healthcare professionals like to hear from their peers, and sets DOL engagement aside as a topic for another time. On generative AI, the guest pushes back on the usual advice. Connor Grennan, Chief AI Architect at NYU Stern and CEO of AI Mindset, disputes the idea that AI tools need arcane, machine-like prompts. Asked whether a model can write a medical publication's first draft, he says he is against it, while stressing that this is his view rather than a fixed rule. A leadership panel that includes Heather Abergele compares publication work at small and large companies, and one panelist describes turf battles that start when a US team disputes the results of a globally led paper. The feed also carries 'Navigating the Non-Negotiables', from a separate ISMPP series called Informed, in which Steve Palmisano of the Lockwood Group and Bob Wright of Sanofi return to a compliance topic they presented at the inaugural ISMPP Academy meeting in September 2023. Credits list Hajar Eldas as producer and editor and end with a pitch for ISMPP membership. The patient-author episode is a good first listen: a long-standing rule, a new case, and guests explaining what they actually do.
Made for: Suits a listener who works in medical publications or medical communications and wants practitioners' answers to concrete problems such as authorship disputes, paying patient authors, or using AI on a first draft.
What sets it apart: It is made by ISMPP and hosted by the organization's own CEO. It treats the field's rules, from GPP and ICMJE criteria to steering committee charters, as open questions, and pushes guests for the operational detail of how those rules are applied.
In Plain Cite, from ISMPP, is the podcast exploring the evolving landscape of medical publication and communication. Each episode delves into the big ideas, trends, and strategies shaping the future of medical publishing. Offering practical tips and insights to help you stay ahead, In Plain Cite is your companion in navigating this dynamic field.
A patient reaches the byline, and suddenly your publication rulebook needs a margin note.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A clear, practical discussion of how publication committees keep trial communications aligned.
Publication steering committees come across here as the quiet infrastructure behind a large clinical trial's public life. Rob Mathias, Cindy Toste, and Paul Resigliano keep the focus on the practical work: setting expectations early, using a charter, and making sure abstracts,…
A grounded panel on bringing social media into medical publication strategy with accuracy and compliance in view.
Social media now sits close to medical publication strategy, especially when teams need to share important publication news with healthcare professionals.
A focused discussion of patient compensation, publication credit, and the limits of recognition.
Patient authorship anchors a careful discussion about ethics, equity, and recognition in medical publishing. Simon Stones, Scientific Director of Patient Engagement at Amica Scientific, approaches the question through equality and equity, while Veronica Horquest, Publications…
A practical review of how company size shapes publication leadership, review workflows, and author approval.
This PlayNext episode treats publication leadership as a practical operating question, shaped by whether a team sits inside a small, midsize, or large company.
A grounded look at using generative AI as a writing partner without letting human voice drift out of the work.
Prompting generative AI is often framed as a technical craft, but this episode keeps returning to a simpler idea: useful prompting often starts with speaking plainly.
Oncology evidence translated into clinical decisions.
Critical care evidence, carefully talked through.
Clinical research, reduced to its practical signal.
Rob Mathias talks with Cindy Toste of GlaxoSmithKline Consumer Healthcare and Paul Resigliano of Daiichi Sankyo about publication steering committees for large clinical trials.
Rob Mathias hosts Amanda Solis, formerly Digital Medical Engagement Team Lead at Pfizer, and Leslie Rotz, Managing Director of Insights and Connections at Fingerpaint Medical, to examine how social media fits into medical publication strategy.
Rob Mathias of VizMap hosts Veronica Horquest of UCB Pharma and Simon Stones of Amica Scientific on In Plain Cite, sponsored by Avalere Health, to debate whether patient authors should be paid.
In Plain Cite’s "Challenges and Opportunities in Publications Leadership" brings together Rob Mathias, Heather Abergele, Suhaida Salaman, and David Ginkle to compare how publications leadership changes at Stoke Therapeutics, Kite Farmer, and AstraZeneca.
Connor Grennan, Chief AI Architect at NYU Stern and CEO of AI Mindset, argues on In Plain Sight that ChatGPT works better when users stop trying to "program" it and start treating it like a colleague.
Stephen Griffiths (GSK), Stephanie Proust (Springer Nature) and patient advocate Stephen Rowley tell host Rob Matthias that content conversion, such as summarizing, translating and simplifying, is the strongest starting use case for generative AI in medical publishing.
Cynthia Bower of the Harwood Center for Health Literacy and Lockwood's Danielle Grosbych tell personal stories, a pregnancy and a mother's pancreatic cancer appointment, that led them to health literacy work.
The CMPP credential began in 2009 as a response to late-1990s problems such as "cherry picking" of positive data and unacknowledged medical writers.
Industry experts discuss navigating compliance and guidelines in medical publications.
This episode discusses digital features in medical publishing, following up on a webinar about their value.
This episode discusses the importance and best practices of plain language summaries in medical publications for non-specialist audiences.
This episode discusses traditional and new metrics for measuring the real-world impact of medical publications.